Annals of Surgery Open (Mar 2022)

Single dose IV Antibiotic for Low-Energy Extremity Gunshot Wounds

  • Mai P. Nguyen, MD,
  • Jonathan C. Savakus, MD,
  • Natasha M. Simske, BS,
  • Michael S. Reich, MD,
  • Ryan Furdock, MD,
  • Joseph F. Golob, Jr., MD,
  • Amy A. McDonald, MD,
  • John J. Como, MD, MPH,
  • Heather A. Vallier, MD

DOI
https://doi.org/10.1097/AS9.0000000000000136
Journal volume & issue
Vol. 3, no. 1
p. e136

Abstract

Read online

Objective:. To prospectively determine infection rate following low-energy extremity GSWs with a single dose IV antibiotic protocol. Summary Background Data:. Previous work suggests that a single IV antibiotic dose, without formal surgical debridement, mitigates infection risk. Methods:. Over 35 months 530 adults with low-energy GSWs to the extremities were included. Three hundred fifty-two patients (66%) had ≥30 days follow-up. Patients were administered a single dose of first-generation IV cephalosporin antibiotics, and those with operative fractures received 24-hour perioperative antibiotics. Injury characteristics, treatment, protocol adherence, and outcomes (infection) were assessed between the protocol group (single-dose antibiotics) and the non-protocol group (no antibiotics or extra doses of antibiotics). Results:. Compliance with the single-dose protocol occurred in 66.8%, while 33.2% received additional antibiotics or no antibiotics. The deep infection rate requiring surgical debridement was 0.8%, while the combined rate of all infections was 11.1%. Age, sex, injury location, multiple injuries, fracture presence, and type of surgery did not affect infection rate. Adherence to the antibiotic protocol was associated with a reduction in infection risk (odds ratio = 0.39, 95% confidence interval 0.19–0.83, P = 0.01). Receipt of additional antibiotics outside of our single-dose protocol did not predict further reduction in rate of infection (P = 0.64). Conclusions:. A standardized protocol of single-dose IV antibiotic appears effective in minimizing infection after low-energy GSW to the extremities. Level of Evidence:. Therapeutic Level II.